Literature DB >> 22043949

HPV vaccines: what remains to be done? Interview by Lauren Constable.

Harald Zur Hausen.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 22043949     DOI： 10.1586/erv.11.128

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN： 1476-0584            Impact factor:   5.217


× No keyword cloud information.
  3 in total

1.  Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of three cohorts from randomized trials.

Authors:  Matti Lehtinen; Camilla Lagheden; Tapio Luostarinen; Tiina Eriksson; Dan Apter; Katja Harjula; Marjo Kuortti; Kari Natunen; Johanna Palmroth; Tiina Petäjä; Eero Pukkala; Mari Siitari-Mattila; Frank Struyf; Pekka Nieminen; Jorma Paavonen; Gary Dubin; Joakim Dillner
Journal:  BMJ Open       Date:  2017-08-18       Impact factor: 2.692

2.  Paediatric Virology as a new educational initiative: An interview with Nobelist Professor of Virology Harald zur Hausen.

Authors:  Ioannis N Mammas; Demetrios A Spandidos
Journal:  Exp Ther Med       Date:  2017-08-23       Impact factor: 2.447

3.  HPV vaccination in boys: Determining the clinical relevance of this strategy.

Authors:  Harald Zur Hausen; Ioannis N Mammas; Demetrios A Spandidos
Journal:  Exp Ther Med       Date:  2017-08-23       Impact factor: 2.447
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.